Clinical Trials and Studies

Breast Cancer

• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer (EMBER-3)
• Breast Cancer Collaborative Registry
• CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-Surgery Chemo and Targeted Therapy
• Estrogen Receptor Status Study
• Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
• Study Assessing the Accuracy of Tumor Biopsies After Chemotherapy
• Study of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer (TAILOR RT)
• The CompassHER2 RD Trial for High Risk HER2-Positive Breast Cancer
• The MATCH Screening Trial
• The ZEST Study for Patients with HER2 Negative or Triple Negative Breast Cancer
• Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer
• Treating Patients With Triple-Negative Breast Cancer